Target intelligence / Profile preview

20S Proteasome (20S)

Target
20S
Molecular classification
Enzyme, Protease, Multi-catalytic protease complex
01

Overview

The 20S proteasome is a large, barrel-shaped multi-catalytic protease complex that serves as the core particle of the eukaryotic and archaeal proteasome system. It is essential for regulated protein degradation in cells, maintaining protein homeostasis by removing misfolded, damaged, or regulatory proteins through an ATP- and ubiquitin-independent mechanism. It is composed of four stacked heptameric rings: two outer α-rings and two inner β-rings. The β-subunits contain three main catalytic sites: β1 (caspase-like), β2 (trypsin-like), and β5 (chymotrypsin-like). Dysregulation contributes to diseases such as cancer and neurodegenerative disorders. Several clinically used drugs inhibit its chymotrypsin-like site to induce apoptosis in cancer cells.

02

Mechanism of action

Inhibition of chymotrypsin-like activity (β5), trypsin-like activity (β2), and caspase-like activity (β1) leads to accumulation of misfolded proteins and induction of apoptosis.

03

Biological functions

Protein quality controlCell cycle regulationAntigen processingProtein degradationCellular stress response
04

Disease associations

CancerNeurodegenerative disease

Beyond the preview

Go deeper on 20S Proteasome (20S).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 20S Proteasome (20S).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call